VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(5.8%),Joseph Edelman(5.8%), etc.
VBI Vaccines | 8-K: VBI Vaccines Reports Third Quarter 2023 Financial Results
VBI Vaccines: Q3 2023 Earnings Report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 8-K: Current report
VBI Vaccines | 10-Q: Q2 2023 Earnings Report
VBI Vaccines | 8-K: VBI Vaccines Reports Second Quarter 2023 Financial Results
VBI Vaccines | 4: Statement of changes in beneficial ownership of securities-Director DeWilde Michel
VBI Vaccines | 4: Statement of changes in beneficial ownership of securities-Director Braga Damian
No Data